“aflibercept” Archives

in
Entry Author Date Location
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies 09/10/18 San Francisco
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
Bluebird, Regeneron Team Up To Make Cell Therapies For Cancer 08/06/18 New York
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
As AMD Race Tightens, Regeneron’s Second Eye Drug Combo Falls Short 11/27/17 New York
Gemini Reels In $42M to Target Root Causes of Age-Related Blindness 10/17/17 Boston
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing 09/11/17 New York
Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More 06/23/17 National
After Setback, Ophthotech Restructures, Dials Down Eye Drug Studies 12/16/16 New York
Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble 12/12/16 New York
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD 10/13/16 Boston
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Avalanche Bio Rolls Onto Nasdaq After Upsized, $102M IPO 07/31/14 San Francisco
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
Kala Pharma Grabs $22.5M More For Eye Drugs 04/23/14 Boston
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Regeneron Targets New Market for Blockbuster Eye Drug 08/06/13 New York
Regeneron Debuts Eye Drug, as Rivals Race to Grab Share of Hot Market 12/01/11 New York
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
Regeneron Shares Halted As FDA Weighs Eye Drug 06/17/11 New York
Regeneron Reports Positive Results in Colon Cancer Trial 04/26/11 New York
Page 1 of 1